Ariad Pharmaceuticals shareholder demands CEO retirement
February 20, 2015 at 18:00 PM EST
Ariad
Pharmaceuticals Inc. (Nasdaq: ARIA) shareholder Sarissa Capital demanded the
retirement of chief executive officer Harvey Berger. The stock price climbed 79 cents to close at $8.06.
